MyFinsight
Home
About
Contact
Back
Income Statement
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
source: myfinsight.com
Download
Download image
Defined benefit pension
plans, net of tax
-$53K
Foreign currency
translation gain (loss)
$7,855K
Comprehensive loss
-$58,712K
(-139.27%↓ Y/Y)
Net other
comprehensive income (loss)
$7,565K
Unrealized (loss) gain on
marketable securities
-$343K
(52.82%↑ Y/Y)
Net loss
-$66,277K
(-292.43%↓ Y/Y)
Loss before income
taxes
-$35,358K
(-216.63%↓ Y/Y)
Provision for income taxes
$30,919K
(440.35%↑ Y/Y)
Collaborations
$61,496K
Product
$672,212K
Royalty
$39,981K
Total other expense,
net
-$19,159K
(67.95%↑ Y/Y)
(loss) income from
operations
-$16,199K
(-133.32%↓ Y/Y)
Interest income
$27,486K
(-5.81%↓ Y/Y)
Total revenues
$773,689K
(17.26%↑ Y/Y)
Interest expense
$40,246K
(21.01%↑ Y/Y)
Total operating costs
and expenses
$789,888K
(29.23%↑ Y/Y)
Other expense, net
-$6,399K
(88.51%↑ Y/Y)
Cost of
collaborations and royalties
$924K
(-34.05%↓ Y/Y)
Cost of goods sold
$142,029K
(111.13%↑ Y/Y)
Research and development
$323,621K
(10.02%↑ Y/Y)
Selling, general and
administrative
$323,314K
(30.16%↑ Y/Y)
Back